Development of DNA macroarrays for rapid detection of drug resistance in Hepatitis B virus
Main Article Content
Abstract
DNA macroarrays containing 7 wild-type probes and 12 mutant-type probes were successfully developed to detect common mutations associated with the resistance of Hepatitis B virus (HBV) to Lamivudine (LAM), Adefovir (ADV) and Entecavir (ETV). These mutations include rtL180M and rtM204V/I, associated with LAM resistance; rtA181T/V and rtN236T, associated with ADV resistance; rtL180M, rtM204V/I, rtT184S/G, rtS202I and rtM250V/I, associated with ETV resistance. The optimal conditions for DNA macroarray hybridization in 2-ml eppendorf tubes were: hybridization temperature of 54℃, rotation speed of 600 rpm, amount of PCR product of 20 µl. Under these optimal conditions, all target mutations were accurately detected by DNA macroarrays without false positive problems due to cross-hybridization. The main advantages of this new method, based on DNA macroarrays for detection of drug resistance in HBV, are rapidity and simplicity (no special equipment required).
Keywords
DNA macroarrays, drug resistance, Hepatitis B virus, mutations, rapid detection
Article Details
References
[1] WHO, Global hepatitis report (2017).
[2] http://www.wpro.who.int/vietnam/topics/hepatitis/factsheet/vi/
[3] T.J. Liang, Hepatitis B: The Virus and Disease, Hepatology. 49 (2009) 13-21.
[4] S. Locarnini, Hepatitis B viral resistance: mechanisms and diagnosis, J Hepatol. 39 (2003) 124-132.
[5] European Association for the Study of the Liver, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol. 67 (2017) 370-398.
[6] J. Fan, Y. Zhang, H. Xiong, Y. Wang, X. Guo, Nucleotide analogue-resistant mutations in hepatitis B viral genomes found in hepatitis B patients, J Gen Virol. 96 (2015) 663-670.
[7] T. Shaw, A. Bartholomeusz, S. Locarnini, HBV drug resistance: Mechanisms, detection and interpretation, J Hepatol. 44 (2006) 593-606.
[8] Y.P. Yang, N. Corley, J. Garcia-Heras, Reverse dot-blot hybridization as an improved tool for the molecular diagnosis of point mutations in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, Mol Diagn. 6 (2001) 193-199.
[9] T.T.T. Bui, T.T. Tran, M.N. Nghiem, P. Rahman , T.T.T. Tran, M.N.H. Dinh, M.H. Le, V.V.C. Nguyen, G. Thwaites, M. Rahman, Molecular characterization of hepatitis B virus in Vietnam, BMC Infect Dis. 17 (2017) 601.
[2] http://www.wpro.who.int/vietnam/topics/hepatitis/factsheet/vi/
[3] T.J. Liang, Hepatitis B: The Virus and Disease, Hepatology. 49 (2009) 13-21.
[4] S. Locarnini, Hepatitis B viral resistance: mechanisms and diagnosis, J Hepatol. 39 (2003) 124-132.
[5] European Association for the Study of the Liver, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol. 67 (2017) 370-398.
[6] J. Fan, Y. Zhang, H. Xiong, Y. Wang, X. Guo, Nucleotide analogue-resistant mutations in hepatitis B viral genomes found in hepatitis B patients, J Gen Virol. 96 (2015) 663-670.
[7] T. Shaw, A. Bartholomeusz, S. Locarnini, HBV drug resistance: Mechanisms, detection and interpretation, J Hepatol. 44 (2006) 593-606.
[8] Y.P. Yang, N. Corley, J. Garcia-Heras, Reverse dot-blot hybridization as an improved tool for the molecular diagnosis of point mutations in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, Mol Diagn. 6 (2001) 193-199.
[9] T.T.T. Bui, T.T. Tran, M.N. Nghiem, P. Rahman , T.T.T. Tran, M.N.H. Dinh, M.H. Le, V.V.C. Nguyen, G. Thwaites, M. Rahman, Molecular characterization of hepatitis B virus in Vietnam, BMC Infect Dis. 17 (2017) 601.